ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
레보티록신나트륨 시장 규모는 향후 몇 년 동안 안정적으로 성장할 것으로 예상됩니다. 2029년에는 47억 8,000만 달러로 성장하여 4.1%의 CAGR을 기록할 것으로 예상됩니다. 예측 기간의 성장은 레보티록신나트륨 제품의 생산, 유통 및 폐기에 영향을 미칠 수 있는 지속가능한 의료 관행에 대한 관심 증가, 품질 보증 기준의 도입, 특히 신흥국에서 의료 비용의 지속적인 증가, 환자 중심 치료 모델로의 전환, 갑상선 건강에 영향을 미치는 환경적 요인에 대한 인식의 증가에 기인합니다. 갑상선 건강에 영향을 미치는 환경적 요인에 대한 인식이 높아졌기 때문인 것으로 보입니다. 예측 기간의 주요 동향으로는 신제품 도입, 장기 이식 관련 새로운 연구, 연구소의 첨단 제형화, 연구개발 확대, 원격의료, e-약국 등을 꼽을 수 있습니다.
향후 5년간 4.1%의 성장률 전망은 지난번 전망치보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 인도와 아일랜드에서 수입되는 합성 갑상선 호르몬 제제 및 안정성 시험 장비의 가격을 급등시켜 갑상선기능저하증 환자의 약품 부족과 만성질환 관리 비용 상승을 초래하여 미국의 내분비 의료에 지장을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
레보티록신나트륨 시장은 갑상선 질환의 심각성으로 인해 성장할 태세를 갖추고 있습니다. 이러한 질환은 목 앞쪽의 갑상선에 영향을 미치며, 진단 지연, 불충분한 치료, 자가면역 반응, 다른 질환의 합병증 등의 요인으로 인해 그 심각성이 증가합니다. 레보티록신나트륨은 갑상선기능저하증과 같은 갑상선 질환에 합성 티록신(T4)을 보충하여 호르몬 수치를 정상으로 되돌리고 관련 증상을 완화하는 데 도움을 줍니다. 예를 들어, 미국암협회는 2024년까지 미국에서 약 44,020명의 갑상선암 환자가 새로 발생할 것으로 예측하고 있으며, 심각한 갑상선 질환이 시장 성장을 주도하고 있음을 강조하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 레보티록신나트륨 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 레보티록신나트륨 시장 : 성장률 분석
세계의 레보티록신나트륨 시장 실적 : 규모와 성장, 2019-2024
세계의 레보티록신나트륨 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 레보티록신나트륨 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 레보티록신나트륨 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
주사
세계의 레보티록신나트륨 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
갑상선기능저하증
갑상선종
갑상선암
점액 수종성 혼수
세계의 레보티록신나트륨 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
기타 용도
세계의 레보티록신나트륨 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
하이퍼마켓
슈퍼마켓
드럭스토어
온라인 스토어
전문점
세계의 레보티록신나트륨 시장 : 하위 세분화 경구, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
경구 용액
세계의 레보티록신나트륨 시장 : 하위 세분화 주사제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
정맥내(IV) 주사
근육내(IM) 주사
제7장 지역별·국가별 분석
세계의 레보티록신나트륨 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 레보티록신나트륨 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
레보티록신나트륨 시장 : 경쟁 구도
레보티록신나트륨 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Novartis AG
GSK plc
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Sandoz International GmbH
Fresenius Kabi
Macleods Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Apotex Inc.
Hikma Pharmaceuticals PLC
Lupin
Amneal Pharmaceuticals Inc.
Glenmark Pharmaceuticals Ltd.
Alvogen
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
레보티록신나트륨 시장 2029 : 새로운 기회를 제공하는 국가
레보티록신나트륨 시장 2029 : 새로운 기회를 제공하는 부문
레보티록신나트륨 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Levothyroxine sodium is a synthetic version of the thyroid hormone thyroxine, utilized in treating hypothyroidism by restoring adequate hormone levels. It plays a crucial role in regulating the body's energy and metabolism, effectively mimicking the function of natural thyroid hormones. This medication is typically prescribed for individuals with an underactive thyroid gland or those who have undergone thyroidectomy.
The primary forms of levothyroxine sodium are oral tablets and injections. Oral levothyroxine sodium consists of synthetic thyroxine (T4) administered orally, primarily used for treating various thyroid conditions such as hypothyroidism, goiter, thyroid cancer, and myxedema coma. These products are distributed through various channels including hypermarkets, supermarkets, drug stores, online platforms, and specialty stores, catering to hospitals, clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The levothyroxine sodium market research report is one of a series of new reports from The Business Research Company that provides levothyroxine sodium market statistics, including the levothyroxine sodium industry global market size, regional shares, competitors with levothyroxine sodium market share, detailed levothyroxine sodium market segments, market trends, and opportunities, and any further data you may need to thrive in the levothyroxine sodium industry. These levothyroxine sodium market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The levothyroxine sodium market size has grown steadily in recent years. It will grow from $3.9 billion in 2024 to $4.07 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increased understanding and recognition of hypothyroidism, rigorous clinical trials and research studies demonstrated the safety and efficacy of Levothyroxine sodium, introduction of generic Levothyroxine sodium formulations provided cost-effective alternatives, training programs and continuing medical education and expanded health insurance coverage for prescription medications.
The levothyroxine sodium market size is expected to see steady growth in the next few years. It will grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing focus on sustainable healthcare practices may influence the production, distribution, and disposal of Levothyroxine sodium products, implementation of quality assurance standards, continued growth in healthcare expenditure, particularly in emerging economies, shifts towards patient-centered care models and heightened awareness of environmental factors affecting thyroid health. Major trends in the forecast period include introduction of a new product, new research on organ transplantation, advanced formulation in laboratories, growing research and development, telemedicine and e-pharmacy.
The forecast of 4.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. endocrine care by inflating prices of synthetic thyroid hormone formulations and stability-testing equipment imported from India and Ireland, resulting in medication shortages and higher chronic disease management costs for hypothyroid patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The levothyroxine sodium market is poised for growth due to escalating severity of thyroid disorders. These conditions affect the thyroid gland, located in the neck's front, and their severity stems from factors such as delayed diagnosis, inadequate treatment, autoimmune reactions, or complications from other medical conditions. Levothyroxine sodium addresses thyroid disorders such as hypothyroidism by supplementing synthetic thyroxine (T4) to restore normal hormone levels and alleviate associated symptoms. For instance, the American Cancer Society predicts approximately 44,020 new cases of thyroid cancer in the US by 2024, highlighting the market's growth driven by severe thyroid disorders.
The higher prevalence of bipolar disorders is expected to drive the levothyroxine sodium market. Bipolar disorders involve extreme shifts in mood, energy, and activity levels, influenced by genetic, biological, and environmental factors such as family history and brain chemistry imbalances. Levothyroxine sodium (L-T4) is used adjunctively for bipolar depression to improve mood stabilization and depressive symptoms by normalizing thyroid hormone levels and altering brain metabolism. For example, the National Study of Mental Health and Wellbeing in Australia reported a prevalence of bipolar affective disorder in males (2.0%) and females (1.8%), underscoring its contribution to the market's growth.
Leading companies in the levothyroxine sodium market are innovating with products such as levothyroxine gel capsules, catering to patients who have difficulty swallowing or need precise dosing. These capsules offer convenient delivery and consistent absorption of levothyroxine, enhancing bioavailability. For instance, IBSA Pharma recently launched Tirosint, a levothyroxine gel capsule and oral liquid solution, which provides customizable FDA-approved dosage strengths (37.5, 44, and 62.5 micrograms). This innovation aims to optimize hypothyroidism treatment by minimizing dose adjustments and empowering clinicians to tailor therapy effectively.
Major companies operating in the levothyroxine sodium market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GSK plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Fresenius Kabi, Macleods Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Lupin, Amneal Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd., Alvogen, IBSA Institut Biochimique SA, Lannett, Taj Pharmaceuticals Ltd., Zydus Cadila, Farmak
North America was the largest region in the levothyroxine sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the levothyroxine sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the levothyroxine sodium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The levothyroxine sodium market consists of sales of synthroid, levoxyl, unithyroid, euthyrox and eltroxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Levothyroxine Sodium Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on levothyroxine sodium market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for levothyroxine sodium ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The levothyroxine sodium market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Oral; Injection
2) By Type: Hypothyroidism; Goiter; Thyroid Cancer; Myxedema Coma
3) By Application: Hospitals; Clinic; Other Applications
4) By Distribution Channel: Hypermarkets; Supermarkets; Drug Stores; Online Stores; Specialty Stores
Subsegments:
1) By Oral: Tablets; Oral Solution
2) By Injection: Intravenous (IV) Injection; Intramuscular (IM) Injection
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Levothyroxine Sodium Market Characteristics
3. Levothyroxine Sodium Market Trends And Strategies
4. Levothyroxine Sodium Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Levothyroxine Sodium Growth Analysis And Strategic Analysis Framework
5.1. Global Levothyroxine Sodium PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Levothyroxine Sodium Market Growth Rate Analysis
5.4. Global Levothyroxine Sodium Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Levothyroxine Sodium Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Levothyroxine Sodium Total Addressable Market (TAM)
6. Levothyroxine Sodium Market Segmentation
6.1. Global Levothyroxine Sodium Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injection
6.2. Global Levothyroxine Sodium Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypothyroidism
Goiter
Thyroid Cancer
Myxedema Coma
6.3. Global Levothyroxine Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinic
Other Applications
6.4. Global Levothyroxine Sodium Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypermarkets
Supermarkets
Drug Stores
Online Stores
Specialty Stores
6.5. Global Levothyroxine Sodium Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Oral Solution
6.6. Global Levothyroxine Sodium Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV) Injection
Intramuscular (IM) Injection
7. Levothyroxine Sodium Market Regional And Country Analysis
7.1. Global Levothyroxine Sodium Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Levothyroxine Sodium Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
